A. Ludwig-Sengpiel
- SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjectsBy O. Holz, S. Khalilieh, A. Ludwig-Sengpiel, H. Watz, P. Stryszak, P. Soni, M. Tsai, J. Sadeh and H. MagnussenO. HolzS. KhaliliehA. Ludwig-SengpielH. WatzP. StryszakP. SoniM. TsaiJ. Sadeh
- ADEPT, airway disease endotyping for personalized treatment: Interim analysis of asthma patientsBy M. Loza, I. Strambu, M. Laviolette, D. Singh, J.M. Fitzgerald, S. Kelsen, A. Eich, A. Ludwig-Sengpiel, G. Chupp, C. Porsbjerg, P. Berger, R. Leigh, J. Kline, M. Dransfield, W. Calhoun, A. Hussaini, P. Chanez, V.S. Susulic, P.E. Silkoff and F. BaribaudM. Loza1Janssen Research & Development, LLC, Spring House, United StatesI. Strambu2ARENSIA and University of Medicine and Pharmacy Bucharest, Bucharest, RomaniaM. Laviolette3Centre De Recherche De L'IUCPQ, Université Laval, Québec, United KingdomD. Singh4Medicines Evaluation Unit, University Hospital of South Manchester NHS Foundation Trust, Manchester, United KingdomJ.M. Fitzgerald5University of British Columbia, Vancouver, CanadaS. Kelsen6Temple University, Philadelphia, United StatesA. Eich7Institute für klinische Forschung Frankfurt, Frankfurt, GermanyA. Ludwig-Sengpiel8KLB Gesundheitsforschung Lübeck, Lübeck, GermanyG. Chupp9Yale University, New Haven, United StatesC. Porsbjerg10Respiratory Research Unit, Bispebjerg University Hospital, Copenhagen, DenmarkP. Berger11Université Bordeaux, Bordeaux, FranceR. Leigh12University of Calgary, Calgary, CanadaJ. Kline13Division of Pulmonary, Critical Care, and Occupational Medicine, University of Iowa, Iowa City, United StatesM. Dransfield14The University of Alabama at Birmingham, Birmingham, United StatesW. Calhoun15University of Texas Medical Branch, Galveston, United StatesA. Hussaini16Parexel International, Baltimore, United StatesP. Chanez17Université de la Méditerranée, Marseille, FranceV.S. Susulic1Janssen Research & Development, LLC, Spring House, United StatesP.E. Silkoff1Janssen Research & Development, LLC, Spring House, United StatesF. Baribaud1Janssen Research & Development, LLC, Spring House, United States
- SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjectsBy O. Holz, S. Khalilieh, A. Ludwig-Sengpiel, H. Watz, P. Stryszak, P. Soni, M. Tsai, J. Sadeh and H. MagnussenArticle | Published in 2009 in European Respiratory JournalO. HolzS. KhaliliehA. Ludwig-SengpielH. WatzP. StryszakP. SoniM. TsaiJ. Sadeh
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.